Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19 Pandemic

AutorMariia Shcherbina - Mykhailo Akimov - Iryna Ozerna - Ilgar Huseynov - Halyna Rossikhina
CargoPostgraduate student - PhD in Legal Sciences - PhD in Law - PhD in Law - Doctor of Law Sciences
Páginas207-223

ISSN 0798- 1406 ~ De pó si to le gal pp 198502ZU132
Cues tio nes Po lí ti cas

IEPDP -Facu ltad d e Ciencia s Ju rídica s y Política s - LUZ
Legal Re spo ns ibi lity fo r Illicit Trade in
Ph arm ace uti cals un de r Con dit ions of th e

DO I: https :/ / doi. org/ 10 .4 63 98 / cu es tpo l.4 07 4.11
M ar iia Sh ch er bi na *
M yk ha il o A ki mo v **
Ir y na Oz er na ***
Ilg a r H us ey n ov ****
Ha ly n a Ro ss ik hin a *****
Abstra ct
The aim of th is st ud y was to examine the optim al types an d
 
       
The resear ch u sed meth ods of system atic approa ch, descrip tive
       
and com parative selection. It has b een estab lish ed that illicit t ra de in


      

      
to the conclusion tha t t he illicit trade in p ha rm aceut icals ma nifests itself
      
           
   
    
       

       
   

   

     
           

        

         
        


Mar iia Sh cherb ina, M yk hailo A kim ov, I ryn a Ozer na, I lgar Huse yno v y H aly na R ossik hina
Legal Res pon sibilit y for Ill icit Tra de in Pha rm aceut icals u nd er Con ditio ns of t he Covid -19
Pan dem ic
Keyw o rds :      

Responsabilidad J urídica por Comercio Ilícito de
Productos Farmacéu ticos en Cond iciones de la Pand emia

Re s um e n
El objetivo de este estud io fue examin ar los tipos y medidas óptim os
           
        
       
    
y compar at ivos. Se ha est ablecido qu e el comercio ilícito de produ ctos

con la cor ru pción y el delito cib ertico. También el art ículo ha revelado
       
        
      
      
        

pr omet edor el desa rro llo de u n mod elo pa ra la activid ad de aplicac ión de la

         
      
    
est os.
Pa lab ras cl ave : 
    

In tr o duc tio n
        
 
safety is the most im port an t comp onent of the provision of m ed ical ca re
 an d the main t ask of health care systems in all
coun trie s of the world.

Para continuar leyendo

Solicita tu prueba

VLEX utiliza cookies de inicio de sesión para aportarte una mejor experiencia de navegación. Si haces click en 'Aceptar' o continúas navegando por esta web consideramos que aceptas nuestra política de cookies. ACEPTAR